Sherlock Biosciences Strengthens Intellectual Property Portfolio in CRISPR-based Diagnostics Through Exclusive License Agreement with Tolo Biotech
Exclusive Rights to Cas12 and Cas13 Maintains Sherlock Biosciences as Leading CRISPR Diagnostic Manufacturer, While…